Influence of halloysite nanotubes on the efficiency of Asparaginase against mice Ehrlich solid carcinoma
- PMID: 35844382
- PMCID: PMC9280262
- DOI: 10.1016/j.sjbs.2022.02.058
Influence of halloysite nanotubes on the efficiency of Asparaginase against mice Ehrlich solid carcinoma
Abstract
Herein, the impact of the halloysite nanotubes to suppress the side effects of Asparaginase (ANase) cellular proliferation was investigated. Methods: A total of 100 adult male mice was employed. These mice were divided into four equal groups; Group 1 (control), Group 2 (ESC group) of a single dose of 0.15 ml Ehrlich cells (2 × 106) intraperitoneal infusion(IP), Group 3 (ESC + ANase group) received six doses equal treatments of Intratumoral (IT) 0.07 ml Aspragnase (7 mg/kg) over two weeks. For two weeks, Group 4 (ESC + ASNase + HNTs) received an IT administration of 0.07 ml Asparaginase stocked on Halloysite nanotubes (HNTs) (30 mg/kg) three times per week. A blood specimen was collected, and the liver was removed to be investigated histologically. Results: TEM measurements for the Halloysite nanoclay showed their tubular cylindrical shape with a mean diameter of 50 nm and an average length of 1 μm, whereas The X-ray diffraction pattern of the Halloysite nanoclay showed their characteristic peaks. ESC increases the serum levels of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and bilirubin than control and other groups, even as albumin and total protein were decreasing. After using Halloysite Nanotube, the rates of these variables were enhanced up to 75%. The hepatocytes histological studies showed protection against Ehrlich Solid carcinoma-induced degenerative, necrotic, and inflammatory changes up to 70%. In conclusion, halloysite nanotubes have demonstrated effective removal of Ehrlich solid carcinoma in mice using an ASNase delivery system. It promoted the ASNase to inhibit the adverse effect of ANase's on the liver and remove the tumour cells.
Keywords: ALB, Albumin; ALP, Alkaline Phosphatase; ALT, Aniline Aminotransferase; ASNase, Asparaginase; AST, Aspartate Aminotransferase; Asparaginase; BCP, bromocresol purple; BD, Bile Duct; CV, Central Vein; DDS, Drug Delivery Systems; EAC, Ehrlich ascites carcinoma; ESC, Ehrlich Solid Carcenoma; HNTs, Halloysite Nanotubes; Halloysite nanotubes, Cancer; Histopathology; IFCC, international federation of clinical chemistry; IM, Intramuscularly; IP, Intraperitoneal; IT, Intratumorally; KAU, King Abdulaziz University; KFMRC, King Fahd Medical Research Center; Liver; Liver functions; PV, Portal Vein; TBIL, Total Bilirubin; TEM, Transmission Electron Microscope; TP, Total protein; XRD, X-Ray Diffraction.
© 2022 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




Similar articles
-
Facile Fabrication of Natural Polyelectrolyte-Nanoclay Composites: Halloysite Nanotubes, Nucleotides and DNA Study.Molecules. 2020 Aug 4;25(15):3557. doi: 10.3390/molecules25153557. Molecules. 2020. PMID: 32759785 Free PMC article.
-
NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).Natl Toxicol Program Tech Rep Ser. 1994 Dec;435:1-288. Natl Toxicol Program Tech Rep Ser. 1994. PMID: 12595928
-
Efficiency of calcium phosphate composite nanoparticles in targeting Ehrlich carcinoma cells transplanted in mice.J Adv Res. 2016 Jan;7(1):143-54. doi: 10.1016/j.jare.2015.04.001. Epub 2015 Apr 22. J Adv Res. 2016. PMID: 26843980 Free PMC article.
-
Preclinical developments of natural-occurring halloysite clay nanotubes in cancer therapeutics.Adv Colloid Interface Sci. 2021 May;291:102406. doi: 10.1016/j.cis.2021.102406. Epub 2021 Mar 29. Adv Colloid Interface Sci. 2021. PMID: 33819725 Review.
-
Nanomaterials: A Review about Halloysite Nanotubes, Properties, and Application in the Biological Field.Int J Mol Sci. 2022 Sep 29;23(19):11518. doi: 10.3390/ijms231911518. Int J Mol Sci. 2022. PMID: 36232811 Free PMC article. Review.
References
-
- Kopeckova K., Eckschlager T., Sirc J., Hobzova R., Plch J., Hrabeta J., Michalek J. Nanodrugs used in cancer therapy. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech Repub. 2019;163(2):122–131. - PubMed
-
- Mo R., Jiang T., Gu Z. Enhanced Anticancer Efficacy by ATP-Mediated Liposomal Drug Delivery. Angew. Chem. Int. Ed. Engl. 2014;53(23):5815–5820. - PubMed
-
- Fang Y., Guo S., Li D., Zhu C., Ren W., Dong S., Wang E. Easy Synthesis and Imaging Applications of Cross -Linked Green Fluorescent Hollow Carbon Nanoparticles. ACS Nano. 2016;1:400–409. - PubMed
-
- Misra R., Acharya S., Sahoo S.K. Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discovery Today. 2010;15(19-20):842–850. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous